Xlife Sciences Ltd. header image

Xlife Sciences Ltd.

XLS

Equity

ISIN CH0461929603 / Valor 46192960

SIX Swiss Exchange (2026-03-27)
CHF 20.60-1.83%

Xlife Sciences Ltd.
UMushroom community rating:

star star star star star
3.50 2 votes No rating yet
NegativeNeutralPositive

About company

The provided company page did not include substantive text, so based on the company name and typical activity in the sector, Xlife Sciences Ltd. is a life‑sciences firm that develops and commercializes health‑related products and services; its business is likely centered on research and development, regulatory interactions and the manufacture or outsourcing of pharmaceuticals, diagnostics or nutraceuticals, with commercial efforts focused on licensing, partnerships and product sales to healthcare providers, distributors and consumers. As with similar small‑to‑mid‑sized life‑sciences companies, value depends on the progress of its development pipeline, regulatory approvals, strategic collaborations and its ability to secure funding and scale manufacturing and distribution.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-7.36%1Y
-35.2%3Y
-56.7%5Y

Performance

63.9%1Y
63.0%3Y
58.3%5Y

Volatility

Market cap

154 M

Market cap (USD)

Daily traded volume (Shares)

530

Daily traded volume (Shares)

1 day high/low

25.9 / 24.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.50

2 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Timo R
Switzerland, 16 Apr 2025
star star star star star
.
Raphael Raufer
Switzerland, 16 Apr 2025
star star star star star
Leider schlechte Performance im Moment

EQUITIES OF THE SAME SECTOR

Janux Therapeutics Inc
Janux Therapeutics Inc Janux Therapeutics Inc Valor: 111742522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.23%USD 13.63
GSK PLC
GSK PLC GSK PLC Valor: 120042705
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.39%USD 53.94
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.22%CHF 3.04
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.31%EUR 2.85
Beiersdorf AG
Beiersdorf AG Beiersdorf AG Valor: 324660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.35%EUR 75.10
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.95%USD 19.11
Amgen Inc
Amgen Inc Amgen Inc Valor: 907582
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.22%USD 353.16
STERIS PLC
STERIS PLC STERIS PLC Valor: 47027903
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.02%USD 223.43
Molina Healthcare Inc
Molina Healthcare Inc Molina Healthcare Inc Valor: 1538184
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.74%USD 138.80
Quest Diagnostics Inc
Quest Diagnostics Inc Quest Diagnostics Inc Valor: 566162
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.86%USD 198.15